Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.40 CAD
Change Today +0.11 / 37.93%
Volume 43.0K
As of 3:53 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

ergoresearch ltd (ERG) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/6/14 - C$0.77
52 Week Low
10/2/15 - C$0.27
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ERGORESEARCH LTD (ERG)

Related News

No related news articles were found.

ergoresearch ltd (ERG) Related Businessweek News

No Related Businessweek News Found

ergoresearch ltd (ERG) Details

Ergoresearch Ltd., through its subsidiaries, manufactures and sells custom foot and general orthotics. It also develops medical equipment for the orthopedic market. The company offers OdrA distraction orthotic device that provides knee mobility by decreasing pain-causing intra-articular pressure; custom fit 3D foot orthotics; motor-powered prosthesis power knee, a motor-powered prosthesis for above-knee amputees; and WebFit system that includes a podo-barometric sensor pad, an optical scanner, and clinical software. It offers services and specialty orthotics in 13 laboratories and approximately 70 satellite offices operating under the Équilibre brand in Quebec. The company was formerly known as Ergo Ventures Inc. and changed its name to Ergoresearch Ltd. in February 2003. Ergoresearch Ltd. was incorporated in 2001 and is headquartered in Laval, Canada.

Founded in 2001

ergoresearch ltd (ERG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$60.0K
Vice-President of Operations
Total Annual Compensation: C$90.0K
Director of Laboratory, Director and Vice Pre...
Total Annual Compensation: C$70.0K
Compensation as of Fiscal Year 2014.

ergoresearch ltd (ERG) Key Developments

Ergoresearch Ltd Announces Earnings Results for the Third Quarter Ended March 31, 2015

Ergoresearch Ltd. announced earnings results for the third quarter ended March 31, 2015. For the quarter, the company's revenues totaled CAD 3,299,994 decreasing by 13.7 % compared to revenues of CAD 3,823,151 for the quarter ended March 31, 2014. This decrease can be explained by the following elements: the closing of Podotech laboratory located in Laval and Laboratoire Langelier clinic also located in Laval. All activities and patients files were transferred to the Équilibre Laval branch. The merge under the unique banner coupled with difficult climatic conditions, which could have affected its clinical visits and could explain part of the decline. The company was not able to provide services to patients on days when professionals were under training in regards to the processes related to the new banner: training of production employees. Staff training on new concepts under 'Équilibre' and new technologies. Net loss after tax amounted to CAD 280,197 compared to net income after tax of CAD 14,466 for the third quarter ended March 31, 2014. The declining results are in part caused by the closure of some offices and changing banners combined with the non- recurring investments for clinical studies launched last quarter. EBITDA loss totalized CAD 146,225 for the quarter compared to EBITDA of CAD 432,167 for the same period last year. Cash flow used in operating activities amounted to CAD 542,605 for the quarter compared to cash flow from operating activities of CAD 242,263 for the same period last year.

Ergoresearch Mulls Acquisitions

Ergoresearch Ltd. (TSXV:ERG) is looking for acquisitions. President and Chief Executive Officer of Ergoresearch, Sylvain Boucher indicated that the company is staying vigilant to any new acquisition opportunities.

Ergoresearch Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2014

Ergoresearch Ltd. reported earnings results for the second quarter ended December 31, 2014. For the quarter, the company reported revenues decreased by 8.8 % and totaled $4,095,112 compared to $4,489,330 for the same period last year. Net income after tax amounted to $1,653 compared to $226,963 for the same period last year. EBITDA reached $243,506 compared to $682,265 for the same period last year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ERG:CN C$0.40 CAD +0.11

ERG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ERG.
View Industry Companies

Industry Analysis


Industry Average

Valuation ERG Industry Range
Price/Earnings 36.6x
Price/Sales 1.7x
Price/Book 1.0x
Price/Cash Flow 38.1x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERGORESEARCH LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at